ArticleDrug design, development and therapy2026

Optimizing Flumatinib Therapy in Chinese Chronic-Phase Chronic Myeloid Leukemia Based on Therapeutic Drug Monitoring.

Fang Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.